Bazemore Robert B
Reporting owner on Forms 3, 4 and 5, CIK 1620152.
Bazemore Robert B reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AKTX · Akari Therapeutics PlcCIK 1541157 | director | 1 | 2026-10-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-10-14 | M exercised | +773 | $0.0004 | 19,666 | Form 4 |
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-10-14 | M exercised | +3,093 | $0.0004 | 22,759 | Form 4 |
| AKTX · Akari Therapeutics PlcPre-Funded Warrant to Purchase ADSs, derivative | 2026-10-14 | M exercised | -773 | $16.16 | 0 | Form 4 |
| AKTX · Akari Therapeutics PlcPre-Funded Warrant to Purchase ADSs, derivative | 2026-10-14 | M exercised | -3,093 | $16.16 | 0 | Form 4 |
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-10-05 | A granted | +4,677 | $7.899 | 18,893 | Form 4 |
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-08-18 | A granted | +13,100 | $7.899 | 14,216 | Form 4 |
| AKTX · Akari Therapeutics PlcStock Option (Right to Buy), derivative | 2026-08-18 | A granted | +45,000 | $0 | 45,000 | Form 4 |
| AKTX · Akari Therapeutics PlcStock Option (Right to Buy), derivative | 2026-08-18 | A granted | +15,000 | $0 | 15,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001493152-26-047455 | Akari Therapeutics Plc | 2026-10-16 |